NL980012I2 - Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. - Google Patents

Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.

Info

Publication number: NL980012I2
Authority: NL; Netherlands
Prior art keywords: preparation; pharmaceutical compositions; mometasone furoate; furoate monohydrate; monohydrate
Prior art date: 1990-09-10

Application number

NL980012C

Other languages

English (en)

Other versions

NL980012I1 (nl

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-10

Filing date

1998-03-12

Publication date

2004-11-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL980012(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-12 Application filed by Schering Ag filed Critical Schering Ag

1998-05-06 Publication of NL980012I1 publication Critical patent/NL980012I1/nl

2004-11-01 Publication of NL980012I2 publication Critical patent/NL980012I2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose

Landscapes

Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)

NL980012C 1990-09-10 1998-03-12 Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. NL980012I2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US58023990A	1990-09-10	1990-09-10
PCT/US1991/006249 WO1992004365A1 (en)	1990-09-10	1991-09-06	Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
NL980012I1 NL980012I1 (nl)	1998-05-06
NL980012I2 true NL980012I2 (nl)	2004-11-01

Family

ID=24320279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL980012C NL980012I2 (nl)	1990-09-10	1998-03-12	Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.

Country Status (35)

Country	Link
US (1)	US6180781B1 (nl)
EP (1)	EP0548114B1 (nl)
JP (1)	JPH0725789B2 (nl)
KR (1)	KR960013445B1 (nl)
CN (1)	CN1030920C (nl)
AT (1)	ATE113604T1 (nl)
AU (1)	AU663471B2 (nl)
BG (1)	BG60755B2 (nl)
CA (1)	CA2091360C (nl)
CZ (1)	CZ281318B6 (nl)
DE (2)	DE19875032I2 (nl)
DK (1)	DK0548114T5 (nl)
EE (1)	EE02962B1 (nl)
ES (1)	ES2065701T3 (nl)
FI (1)	FI111078B (nl)
HK (1)	HK185996A (nl)
HR (1)	HRP920383B1 (nl)
HU (1)	HU213401B (nl)
IE (1)	IE67056B1 (nl)
IL (1)	IL99437A (nl)
LU (1)	LU90366I2 (nl)
MX (2)	MX9203396A (nl)
MY (1)	MY106644A (nl)
NL (1)	NL980012I2 (nl)
NO (1)	NO300548B1 (nl)
NZ (1)	NZ239711A (nl)
OA (1)	OA09772A (nl)
PH (1)	PH30443A (nl)
PL (1)	PL165803B1 (nl)
PT (1)	PT98905B (nl)
SI (1)	SI9111497A (nl)
TW (2)	TW229208B (nl)
WO (1)	WO1992004365A1 (nl)
YU (1)	YU48666B (nl)
ZA (1)	ZA917148B (nl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ281318B6 (cs) *	1990-09-10	1996-08-14	Schering Corporation	Monohydrát mometasonfuroátu, způsob přípravy této látky a přípravy lékových kompozic z ní
PE44995A1 (es) *	1994-01-27	1995-12-18	Schering Corp	Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) *	1994-01-27	1998-11-17	Schering Corporation	Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) *	1996-07-01	1999-03-23	Schering Corporation	Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en)	1996-07-03	1999-11-02	Rorer Pharmaceutical Products Inc.	Aqueous-based pharmaceutical composition
CN1059476C (zh) *	1996-08-21	2000-12-13	邓维鹏	金黄色铝合金硒盐电解着色方法
US6187765B1 (en) *	1997-10-09	2001-02-13	Schering Corporation	Mometasone furoate suspensions for nebulization
AU9674398A (en) *	1997-10-09	1999-05-03	Schering Corporation	Mometasone furoate suspensions for nebulization
MY133181A (en) *	1998-09-10	2007-10-31	Schering Corp	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
GB0207906D0 (en) *	2002-04-05	2002-05-15	3M Innovative Properties Co	Formoterol and mometasone aerosol formulations
US9808471B2 (en)	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US7811606B2 (en)	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
AU2004268847A1 (en) *	2003-08-29	2005-03-10	Ranbaxy Laboratories Limited	Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) *	2003-11-26	2007-11-08	Palle Venkata P	Phosphodiesterase Inhibitors
US7491725B2 (en)	2004-02-06	2009-02-17	Bristol-Myers Squibb Company	Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
WO2007031838A1 (en)	2005-09-16	2007-03-22	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) *	2005-10-07	2007-05-03	Cheryl Lynn Calis	Anhydrous mometasone furoate formulation
US20090221664A1 (en)	2005-10-19	2009-09-03	Abhijit Ray	Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (en) *	2005-10-19	2008-07-30	Ranbaxy Laboratories, Ltd.	Compositions of phosphodiesterase type iv inhibitors
CN100436473C (zh) *	2005-12-09	2008-11-26	天津药业集团有限公司	糠酸莫美他松中间体21-酯及制法
CN100389121C (zh) *	2005-12-09	2008-05-21	天津药业集团有限公司	糠酸莫美他松中间体21-羟的制备方法
DE102006034883A1 (de) *	2006-07-25	2008-01-31	Hermal Kurt Herrmann Gmbh & Co. Ohg	Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
US20100029728A1 (en) *	2006-09-22	2010-02-04	Ranbaxy Laboratories Limited	Phosphodiesterase inhibitors
US20110021473A1 (en) *	2006-09-22	2011-01-27	Ranbaxy Laboratories Limited	Inhibitors of phosphodiesterase type-iv
US20080207659A1 (en) *	2007-02-15	2008-08-28	Asit Kumar Chakraborti	Inhibitors of phosphodiesterase type 4
JP5671236B2 (ja) *	2007-03-14	2015-02-18	ランバクシーラボラトリーズリミテッド	ホスホジエステラーゼ阻害剤としてのピラゾロ（３，４−ｂ）ピリジン誘導体
US20110130403A1 (en) *	2007-03-14	2011-06-02	Ranbaxy Laboratories Limited	Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type IV inhibitors
PL3106149T3 (pl)	2009-05-29	2020-06-01	Pearl Therapeutics, Inc.	Kompozycje do płucnego dostarczania długo-działających antagonistów muskarynowych i długo-działających agonistów receptora beta-2 adrenergicznego oraz powiązane sposoby i układy
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt)	2010-04-21	2013-04-17	Hovione Farmaciencia S A	Processo para processamento de partículas de ingredientes activos farmacêuticos
KR102391332B1 (ko)	2013-03-15	2022-04-26	펄 테라퓨틱스 인코포레이티드	미립자 결정질 재료를 컨디셔닝하는 방법 및 시스템
CN107260671B (zh) *	2016-04-08	2021-03-26	天津金耀集团有限公司	一种糠酸莫米松混悬鼻喷剂组合物
CN107266518B (zh) *	2016-04-08	2021-03-30	天津金耀集团有限公司	一种糠酸莫米松晶型及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE8790T1 (de) *	1981-02-02	1984-08-15	Schering Corporation	Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
US4783444A (en)	1984-09-17	1988-11-08	Schering Corporation	Antiglaucoma compositions and methods
US4808610A (en) *	1986-10-02	1989-02-28	Schering Corporation	Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) *	1987-05-21	1988-10-04	Schering Corporation	Steroid lotion
CZ281318B6 (cs) *	1990-09-10	1996-08-14	Schering Corporation	Monohydrát mometasonfuroátu, způsob přípravy této látky a přípravy lékových kompozic z ní

1991
- 1991-09-06 CZ CZ93383A patent/CZ281318B6/cs not_active IP Right Cessation
- 1991-09-06 EP EP91915453A patent/EP0548114B1/en not_active Expired - Lifetime
- 1991-09-06 PL PL91298223A patent/PL165803B1/pl unknown
- 1991-09-06 ES ES91915453T patent/ES2065701T3/es not_active Expired - Lifetime
- 1991-09-06 JP JP3514768A patent/JPH0725789B2/ja not_active Expired - Lifetime
- 1991-09-06 WO PCT/US1991/006249 patent/WO1992004365A1/en active IP Right Grant
- 1991-09-06 AU AU84974/91A patent/AU663471B2/en not_active Expired
- 1991-09-06 DK DK91915453.4T patent/DK0548114T5/da active
- 1991-09-06 DE DE1991604991 patent/DE19875032I2/de active Active
- 1991-09-06 HU HU9300685A patent/HU213401B/hu unknown
- 1991-09-06 CA CA002091360A patent/CA2091360C/en not_active Expired - Lifetime
- 1991-09-06 DE DE69104991T patent/DE69104991T2/de not_active Expired - Lifetime
- 1991-09-06 IL IL9943791A patent/IL99437A/en not_active IP Right Cessation
- 1991-09-06 AT AT91915453T patent/ATE113604T1/de active
- 1991-09-06 MX MX9203396A patent/MX9203396A/es unknown
- 1991-09-06 KR KR1019930700702A patent/KR960013445B1/ko not_active IP Right Cessation
- 1991-09-09 SI SI9111497A patent/SI9111497A/sl unknown
- 1991-09-09 PH PH43072A patent/PH30443A/en unknown
- 1991-09-09 IE IE315591A patent/IE67056B1/en not_active IP Right Cessation
- 1991-09-09 MX MX9100990A patent/MX9100990A/es unknown
- 1991-09-09 MY MYPI91001630A patent/MY106644A/en unknown
- 1991-09-09 TW TW080107102A patent/TW229208B/zh not_active IP Right Cessation
- 1991-09-09 PT PT98905A patent/PT98905B/pt not_active IP Right Cessation
- 1991-09-09 ZA ZA917148A patent/ZA917148B/xx unknown
- 1991-09-09 TW TW083106101A patent/TW272195B/zh not_active IP Right Cessation
- 1991-09-09 NZ NZ239711A patent/NZ239711A/en not_active IP Right Cessation
- 1991-09-09 YU YU149791A patent/YU48666B/sh unknown
- 1991-09-10 CN CN91108910A patent/CN1030920C/zh not_active Expired - Lifetime
1992
- 1992-09-21 HR HRP-1497/91A patent/HRP920383B1/xx not_active IP Right Cessation
1993
- 1993-02-26 NO NO930693A patent/NO300548B1/no not_active IP Right Cessation
- 1993-03-09 OA OA60348A patent/OA09772A/en unknown
- 1993-03-09 FI FI931031A patent/FI111078B/fi not_active IP Right Cessation
1994
- 1994-02-24 BG BG098564A patent/BG60755B2/bg unknown
- 1994-11-21 EE EE9400388A patent/EE02962B1/xx unknown
1995
- 1995-04-17 US US08/422,479 patent/US6180781B1/en not_active Expired - Lifetime
1996
- 1996-10-03 HK HK185996A patent/HK185996A/xx not_active IP Right Cessation
1998
- 1998-03-12 NL NL980012C patent/NL980012I2/nl unknown
1999
- 1999-03-05 LU LU90366C patent/LU90366I2/xx unknown

Also Published As

Publication number	Publication date
NL980012I1 (nl)	1998-05-06
TW229208B (nl)	1994-09-01
IE913155A1 (en)	1992-03-11
ES2065701T3 (es)	1995-02-16
DE69104991D1 (de)	1994-12-08
MX9203396A (es)	1992-07-31
YU149791A (sh)	1994-01-20
HUT64361A (en)	1993-12-28
US6180781B1 (en)	2001-01-30
HU213401B (en)	1997-06-30
PT98905A (pt)	1992-09-30
JPH0725789B2 (ja)	1995-03-22
OA09772A (en)	1993-11-30
PL165803B1 (pl)	1995-02-28
HU9300685D0 (en)	1993-06-28
YU48666B (sh)	1999-06-15
CZ38393A3 (en)	1994-01-19
KR960013445B1 (ko)	1996-10-05
HK185996A (en)	1996-10-11
JPH05506667A (ja)	1993-09-30
DE69104991T2 (de)	1995-04-20
MY106644A (en)	1995-07-31
ZA917148B (en)	1992-08-26
PH30443A (en)	1997-05-09
HRP920383B1 (en)	2000-04-30
IE67056B1 (en)	1996-02-21
FI931031A (fi)	1993-03-09
IL99437A (en)	1995-05-29
MX9100990A (es)	1992-05-04
CA2091360C (en)	1997-04-08
NO930693D0 (no)	1993-02-26
DK0548114T5 (da)	1995-01-30
NZ239711A (en)	1992-09-25
CN1059911A (zh)	1992-04-01
BG60755B2 (bg)	1996-02-29
FI111078B (fi)	2003-05-30
IL99437A0 (en)	1992-08-18
EP0548114B1 (en)	1994-11-02
AU663471B2 (en)	1995-10-12
FI931031A0 (fi)	1993-03-09
DE19875032I2 (de)	2007-04-19
EP0548114A1 (en)	1993-06-30
CN1030920C (zh)	1996-02-07
ATE113604T1 (de)	1994-11-15
NO300548B1 (no)	1997-06-16
AU8497491A (en)	1992-03-30
WO1992004365A1 (en)	1992-03-19
CA2091360A1 (en)	1992-03-11
HRP920383A2 (en)	1998-06-30
SI9111497A (sl)	1998-04-30
EE02962B1 (et)	1997-02-17
NO930693L (no)	1993-02-26
CZ281318B6 (cs)	1996-08-14
LU90366I2 (fr)	1999-05-05
TW272195B (nl)	1996-03-11
PT98905B (pt)	1998-08-31

Publication	Publication Date	Title
NL980012I2 (nl)	2004-11-01	Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
NZ240230A (en)	1993-01-27	Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
UA34428C2 (uk)	2001-03-15	Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
MA22842A1 (fr)	1993-10-01	Procede de preparation de compositions de vaccin.
GB8823567D0 (en)	1988-11-16	4h-1-benzopyran-4-one derivative/its salt & process for producing same
RU93004445A (ru)	1995-08-20	Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
IL58782A (en)	1984-02-29	Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
IT1190824B (it)	1988-02-24	Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
GR1001597B (el)	1994-06-30	Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
FI954931A0 (fi)	1995-10-17	Uusia piperidinyylitioindolin johdannaisia, niiden valmistusmenetelmä, niitä sisältäviä farmaseuttisia koostumuksia, jotka ovat käyttökelpoisia erityisesti kivun lievittäjinä
IT7927243A0 (it)	1979-11-13	Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
ES8604731A1 (es)	1985-09-01	Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
ES474052A1 (es)	1979-04-16	Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
DE69614552D1 (de)	2001-09-20	MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
IT8220979A0 (it)	1982-04-28	Derivato della propionilglicina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono come principio attivo.